Because the CONCERTA tablet is nondeformable and does not appreciably change in shape within the GI tract, CONCERTA shouldn't ordinarily be administered to patients with preexisting intense gastrointestinal narrowing (pathologic or iatrogenic, as an example: esophageal motility Ailments, modest bowel inflammatory disorder, "shorter gut" syndrome as